**Eli Lilly’s Zepbound Successfully Treats Sleep Apnea In Landmark Clinical Trial Results** episode artwork

EPISODE · Mar 5, 2026 · 15 MIN

**Eli Lilly’s Zepbound Successfully Treats Sleep Apnea In Landmark Clinical Trial Results**

from AI Daily Pulse · host Healthcare Daily Pulse

Intelligence Brief:CMS Receives Record Comments on 2026 Medicare Advantage RulePK Consumer Health Acquires HealthAid in EUR 100M EBITDA PlayOverlake Medical Deploys Agentic AI for 349-Bed SystemCMS Issues 30 Warning Letters to Telehealth GLP-1 PlatformsPwC Predicts 2026 Healthcare M&A Rebound Driven by AIArdent Health Implements AI Helpers in 2000 Patient RoomsCMS Proposes 10-Year Catastrophic Plan Terms for 2027.**[START AUDIO]** **ALEX:** We’re looking at a landscape where the "move fast and break things" era just hit the brick wall of actuarial reality. I’m Alex, and this is Healthcare Daily Pulse. **Sam:** And I’m Sam. We’re coming to you from the war room where the numbers are finally catching up to the narratives. Alex, the market’s been treating healthcare tech like a software play for five years, but the Q3 earnings calls we’re seeing? They’re a wake-up call for anyone who thinks a shiny UI sol...

Episode metadata supplied by the publisher feed · Published Mar 5, 2026

Embed this episode

NOW PLAYING

**Eli Lilly’s Zepbound Successfully Treats Sleep Apnea In Landmark Clinical Trial Results**

0:00 15:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of AI Daily Pulse?

This episode is 15 minutes long.

When was this AI Daily Pulse episode published?

This episode was published on March 5, 2026.

Can I download this AI Daily Pulse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!